Litcius/Paper detail

Clinical features and mechanistic insights into drug repurposing for combating COVID-19

Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, Kielan Darcy McAlinden, Greg Haug, Matt D. Johansen, Philip M. Hansbro, Katie L. Flanagan, Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal

2021The International Journal of Biochemistry & Cell Biology16 citationsDOIOpen Access PDF

Topics & Concepts

Cytokine stormRepurposingMedicineCoronavirus disease 2019 (COVID-19)Drug repositioningPandemicIntensive care medicineCoronavirusPneumoniaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical trialDrugDrug developmentDiseasePharmacologyInfectious disease (medical specialty)BiologyInternal medicineEcologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19
Clinical features and mechanistic insights into drug repurposing for combating COVID-19 | Litcius